Background
Methods
Setting
Instrument and design
Statistical analysis and ethical approval
Results
Sociodemographic characteristics
Variable | Detainees with at least one medical consultation N = 1510 | Detainees without medical consultation N = 685 | All detainees N = 2195 |
---|---|---|---|
Age (years (SD, range)) | 30.1 (9.8, 18-82) | 28.0 (8.8, 18-71)* | 29.5 (9.5, 18-82)* |
Sex male (n) | 95% (1434) | 95% (653) | 95% (2087) |
Length of stay in prison (days (SD, range)) | 98 (179, 1-2635)** | 37 (89, 1-1010)*** | 80 (160, 1-2635)**** |
Origin (continent and 5 most frequent countries): | |||
Western Europe§§ | 27.4% (413) | 32.7% (208) | 28.9% (621) |
France | 8.9% (135) | 9.4% (60) | 9.1% (195) |
Switzerland | 7.7% (116) | 8.6% (61) | 8.2% (177) |
Italy | 2.3% (35) | 2.4% (15) | 2.3% (50) |
Portugal | 2.1% (31) | 2.7% (17) | 2.2% (48) |
Spain | 2.1% (31) | 1.1% (7) | 1.8% (38) |
Eastern Europe | 14.6% (221) | 22.0% (140) | 16.8% (361) |
Albania | 5.5% (83) | 13.8% (88) | 8.0% (171) |
Romania | 2.0% (30) | 4.6% (29) | 2.7% (59) |
Russia | 2.7% (40) | 0.6% (4) | 2.1% (44) |
Kosovo | 1.7% (25) | 0.9% (6) | 1.4% (31) |
ex-Yugoslavia§ | 1.6% (22) | 1.4% (9) | 1.4% (31) |
North Africa and Middle East | 30.6% (461) | 20.3% (129) | 27.5% (590) |
Algeria | 15.8% (239) | 8.6% (55) | 13.7% (294) |
Palestine | 5.8% (88) | 3.1% (20) | 5.0% (108) |
Iraq | 3.6% (55) | 2.2% (14) | 3.2% (69) |
Morocco | 3.6% (54) | 1.7% (11) | 3.0% (65) |
Tunisia | 1.7% (26) | 2.5% (16) | 2.0% (42) |
Sub-Saharan Africa | 20.9% (315) | 18.2% (116) | 20.1% (432) |
Guinea | 5.2% (78) | 5.3% (34) | 5.2% (112) |
Sierra Leone | 1.9% (29) | 1.6% (10) | 1.8% (39) |
Ivory Coast | 1.5% (23) | 1.6% (10) | 1.5% (33) |
Congo | 1.1% (16) | 1.4% (9) | 1.2% (25) |
Mali | 1.0% (15) | 1.3% (8) | 1.1% (23) |
Asia | 3.8% (57) | 2.2% (14) | 3.3% (71) |
Georgia | 2.7% (41) | 1.1% (7) | 2.2% (48) |
Vietnam | 0.2% (3) | 0.5% (1) | 0.2% (4) |
Philippines | 0.2% (3) | - | 0.1% (3) |
Azerbaijan | 0.1% (2) | - | 0.1% (2) |
Uzbekistan | 0.1% (2) | - | 0.1% (2) |
America | 2.8% (42) | 4.4% (28) | 3.3% (70) |
Chile | 0.7% (11) | 0.6% (4) | 0.7% (15) |
Brazil | 0.7% (10) | 0.8% (5) | 0.7% (15) |
Peru | 0.3% (4) | 0.6% (4) | 0.4% (8) |
Colombia | 0.1% (2) | 0.9% (6) | 0.4% (8) |
Jamaica | 0.3% (4) | 0.2% (1) | 0.2% (5) |
ICPC coded health problems
Symptoms or complaints without precise diagnosis
Category (common examples) | Males | Females | All detainees | Prevalence data general population | |||
---|---|---|---|---|---|---|---|
N = 2087 | N = 108 | N = 2195 | |||||
N | % (95% CI) | N | 42.6 (33.3-51.9) | N | % (95% CI) | % | |
A. Symptoms without precise diagnosis | 880 | 42.2 (40.0-44.3) | 46 | 14.8 (8.1-21.5) | 926 | 42.2 (40.1-44.3) | |
Insomnia, sleep disturbance | 310 | 14.9 (13.3-16.4) | 16 | 19.4 (12.0-26.9) | 326 | 14.9 (13.4-16.3) | 4.1-6.9 [26]* |
Anxiety, nervousness, irritability, anger | 226 | 10.8 (9.5-12.2) | 21 | 6.5 (1.8-11.1) | 247 | 11.3 (9.9-12.6) | |
Back pain | 154 | 7.4 (6.3-8.5) | 7 | 6.5 (1.8-11.1) | 161 | 7.3 (6.2-8.4) | 5.2-8.8 [26]* |
Epigastralgia, dyspepsia, pyrosis | 96 | 4.6 (3.7-5.5) | 3 | 2.8 (0.0-5.9) | 99 | 4.5 (3.6-5.4) | 3.7-4.4 [26]* |
Pain (not specified) | 89 | 4.3 (3.4-5.1) | 2 | 1.9 (0.0-4.4) | 91 | 4.1 (3.3-5.0) | |
B. Infectious diseases | 485 | 23.2 (21.4-25.1) | 31 | 28.7 (20.2-37.2) | 516 | 23.5 (21.7-25.3) | |
Upper airways infection | 155 | 7.4 (6.3-8.6) | 13 | 12.0 (5.9-18.2) | 168 | 7.7 (6.5-8.8) | |
Mycosis (genital excepted) | 138 | 6.6 (5.6-7.8) | 2 | 1.8 (0.0-4.3) | 140 | 6.4 (4.0-5.8) | |
Folliculitis, Furunculosis | 59 | 2.8 (2.1-3.5) | 1 | 0.9 (0.0-2.7) | 60 | 2.7 (2.1-3.4) | |
Other prison relevant infections: | |||||||
Pediculosis, scabies | 19 | 0.9 (0.5-1.3) | 0 | 19 | 0.9 (0.5-1.3) | ||
Hepatitis B (chronic active) | 22 | 1.1 (0.6-1.5) | 0 | 7.4 (2.5-12.3) | 22 | 1.0 (0.6-1.4) | 0.2 [36] |
Hepatitis C | 118 | 5.7 (4.7-6.6) | 8 | 7.4 (2.5-12.3) | 126 | 5.7 (4.8-6.7) | 0.7-1.0 [20] |
HIV, AIDS | 19 | 0.9 (0.5-1.3) | 5 | 2.8 (0-5.9) | 22 | 1.0 (0.6-1.4) | 0.3 [36] |
Tuberculosis (active) | 5 | 0.2 (0.0-0.4) | 3 | 5 | 0.2 (0.0-0.6) | 0.006 [19] | |
C. General internal medicine | 319 | 29.7 (27.7-31.6) | 37 | 34.3 (25.3-43.2) | 656 | 29.9 (28.0-31.8) | |
Xerosis with pruritus | 143 | 6.9 (5.8-7.9) | 2 | 1.9 (0.0-4.4) | 145 | 6.6 (5.6-7.6) | |
Asthma | 67 | 3.2 (2.5-4.1) | 3 | 2.8 (0.0-5.9) | 70 | 3.2 (2.5-3.9) | 2.5 [25] |
Acne | 51 | 2.4 (1.8-3.1) | 4 | 3.7 (0.1-7.3) | 55 | 2.5 (1.9-3.2) | |
Eye disease (without conjunctivitis) | 54 | 2.6 (1.9-3.3) | 1 | 0.9 (0.0-2.7) | 55 | 2.5 (1.9-3.2) | |
Hypertension (arterial) | 47 | 2.3 (1.6-2.9) | 6 | 5.6 (1.2-9.9) | 53 | 2.4 (1.8-3.1) | 2.5-7.6 [24]* |
Allergy | 45 | 2.2 (1.5-2.8) | 5 | 4.6 (0.7-8.6) | 50 | 2.3 (1.7-2.9) | |
Eczema | 47 | 2.3 (1.6-2.9) | 2 | 1.9 (0.0-4.4) | 49 | 2.2 (1.6-2.9) | |
Dyslipidemia, hypercholesterolemia | 42 | 2.0 (1.4-2.6) | 3 | 2.8 (0.0-5.9) | 45 | 2.1 (1.5-2.6) | 1.1-6.3 [24]* |
Hemorrhoids | 39 | 1.9 (1.3-2.4) | 1 | 0.9 (0.0-2.7) | 40 | 1.8 (1.3-2.4) | |
Migraine, tension headache | 32 | 1.5 (1.0-2.1) | 5 | 4.6 (0.7-8.6) | 37 | 1.7 (1.1-2.2) | 7.7-9.3 [26] |
D. Injuries | 392 | 18.8 (17.1-20.5) | 9 | 8.3 (3.1-13.5) | 401 | 18.3 (16.7-19.9) | 13.7-25.7 [24]* |
Alleged victim of violence | 166 | 8.0 (6.8-9.1) | 7 | 6.5 (1.7-11.1) | 173 | 7.9 (6.8-9.0) | |
Contusion (without skin lesion) | 141 | 6.8 (5.7-7.8) | 7 | 6.5 (1.8-11.1) | 148 | 6.7 (5.7-7.8) | |
Contusion (with skin lesion) | 124 | 5.9 (4.9-7.0) | 3 | 2.8 (0.0-5.9) | 127 | 5.8 (4.8-6.8) | |
Sprained ankle | 41 | 2.0 (1.4-2.6) | 1 | 0.9 (0.0-2.7) | 42 | 1.9 (1.3-2.5) | |
Periarticular lesion | 33 | 1.6 (1.0-2.1) | 0 | 33 | 1.5 (1.0-2.0) | ||
Self harm | 98 | 4.7 (3.8-5.6) | 2 | 1.9 (0.0-4.4) | 100 | 4.6 (3.7-5.4) | |
During imprisonment | 50 | 2.4 (1.7-3.1) | 1 | 0.9 (0.0-2.7) | 51 | 2.3 (1.7-3.0) | |
Previous | 57 | 2.7 (2.0-3.4) | 1 | 0.9 (0.0-2.7) | 58 | 2.6 (2.0-3.3) |
Substance abuse
Category (common examples) | Males | Females | All detainees | Prevalence data: General population | |||
---|---|---|---|---|---|---|---|
N = 2087 | N = 108 | N = 2195 | |||||
N | % (95% CI) | ||||||
E. Substance abuse | |||||||
Substance abuse (licit) | 1502 | 72.0 (70.0-73.9) | 60 | 55.6 (46.2-64.9) | 1562 | 71.2 (69.3-73.1) | |
Tobacco (active) | 1296 | 62.1 (60.0-64.2) | 55 | 50.9 (41.5-60.4) | 1351 | 61.5 (59.5-63.6) | 29.3-37.2 [24]* |
Alcohol misuse | 750 | 35.9 (33.9-38.0) | 13 | 12.0 (5.9-18.2) | 763 | 34.8 (32.8-36.8) | 3.9-4.8 [24]* |
Benzodiazepine (not medically prescribed) | 465 | 22.3 (20.5-24.1) | 13 | 12.0 (5.9-18.2) | 478 | 21.8 (20.1-23.5) | |
Illicit drug use (active): | 852 | 40.8 (38.7-42.9) | 31 | 28.7 (20.2-37.2) | 883 | 40.2 (38.2-42.3) | |
Cannabis | 605 | 29.0 (27.0-30.9) | 19 | 17.6 (10.4-24.8) | 624 | 28.4 (26.5-30.3) | 9.3 [24] |
Cocaine | 418 | 20.0 (18.3-21.7) | 10 | 9.3 (3.8-14.7) | 428 | 19.5 (17.8-21.2) | 2.8 [21]** |
Heroine | 255 | 12.2 (10.8-13.6) | 14 | 13.0 (6.6-19.3) | 269 | 12.3 (10.9-13.6) | 0.7 [21]** |
Illicit drug use (lifetime): | 720 | 34.5 (32.5-36.5) | 21 | 19.4 (12.0-26.9) | 741 | 33.8 (31.8-35.7) | |
Cocaine | 673 | 32.2 (30.2-34.3) | 17 | 15.7 (8.9-22.6) | 690 | 31.4 (29.5-33.4) | 2.8 [21]* |
Heroine | 369 | 17.7 (16.0-19.3) | 17 | 15.7 (8.9-22.6) | 386 | 17.6 (16.0-19.2) | 0.7 [21]** |
F. Psychiatry | 332 | 15.9 (14.3-17.5) | 27 | 25.0 (16.8-17.9) | 359 | 16.4 (14.8-17.9) | |
Depression | 145 | 6.9 (5.9-8.0) | 18 | 16.7 (9.6-23.7) | 163 | 7.4 (6.3-8.5) | 2-9% major depression [29] |
Personality disorder | 111 | 5.3 (4.4-6.3) | 9 | 8.3 (3.1-13.5) | 120 | 5.5 (4.5-6.4) | 1-3% antisocial personality disorder [29] |
Adjustment disorder | 90 | 4.3 (3.4-5.2) | 8 | 7.4 (2.5-12.3) | 98 | 4.5 (3.6-5.3) | 5-20% in individuals seeking outpatient mental health treatment [29] |
Post Traumatic Stress Disorder | 22 | 1.1 (0.6-1.5) | 0 | 22 | 1.0 (0.6-1.4) | 1-14% [29] | |
Psychosis (schizophrenia, delirium) | 17 | 0.8 (0.4-1.2) | 4 | 3.7 (0.0-7.3) | 21 | 1.0 (0.5-1.4) | 0.2-2% schizophrenia [29] |
Bipolar disorder | 2 | 0.1 (0.0-0.2) | 0 | 2 | 0.1 (0.0-0.2) | 0.4-1.6 [29] |